Empliciti 400 mg

Empliciti (elotuzumab) is a medication used in combination with lenalidomide and dexamethasone in the treatment of multiple myeloma in patients who have previously received one to three treatments.

The active ingredient in Empliciti is elotuzumab, a monoclonal antibody that activates the body's immune cells to attack multiple myeloma cancer cells. It achieves this by binding to a protein on the surface of immune cells called SLAMF7, leading them to act against cancer cells and thereby slowing down the progression of the disease. Elotuzumab also binds to SLAMF7 on cancer cells, making them more vulnerable to attacks by immune cells.

Empliciti 400 mg​ You can contact us to find out the price:

Contact for detailed information
Important Notice: We do not have any activities such as drug sales, drug supply or drug promotion on our site. In addition, there is no help or counseling service on medical matters on our site. All information on the site has been prepared for patients and doctors to have information about drugs. Our site is not under legal responsibility for the incomplete or not updated information on our site. Our users entering the site are deemed to have accepted these conditions. Please consult your doctor before using medication.
Related Keywords

Contact Now

You can contact us immediately to get information about our products and services, and to get answers to your questions.

Contact Now